These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7312991)

  • 1. Spironolactone inhibits vascular reactivity by a prostaglandin related mechanism unconnected with aldosterone.
    Oka M; Manku MS
    Prostaglandins Med; 1981 Oct; 7(4):305-19. PubMed ID: 7312991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between dopamine and prostaglandins on vascular reactivity to noradrenaline: dopamine inhibits the action of PGE1.
    Oka M; Manku MS; Horrobin DF
    Prostaglandins Med; 1981 Oct; 7(4):267-80. PubMed ID: 6947304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of captopril and prostaglandin I2 on vasoconstrictor responses to norepinephrine and potassium ions in rat mesenteric artery.
    Kondo K; Okuno T; Suzuki H; Handa M; Saruta T
    Jpn Heart J; 1981 Jul; 22(4):617-25. PubMed ID: 6272000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper inhibits pressor responses to noradrenaline but not potassium. Interactions with prostaglandins E1, E2, and I2 and penicillamine.
    Cunnane SC; Zinner H; Horrobin DF; Manku MS; Morgan RO; Karmali RA; Ally AI; Karmazyn M; Barnette WE; Nicolaou KC
    Can J Physiol Pharmacol; 1979 Jan; 57(1):35-40. PubMed ID: 371766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydralazine inhibits vascular reactivity by a mechanism independent of vascular prostaglandin biosynthesis: role of thromboxane synthetase in blocking hydralazine actions.
    Ally AI; Horrobin DF
    Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):39-63. PubMed ID: 3462852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of rates of excretion of urinary prostaglandin E metabolites to administration of angiotensin, aldosterone, and spironolactone in vivo.
    Fretland DJ; Cammarata PS
    Prostaglandins Leukot Med; 1984 Apr; 14(1):65-78. PubMed ID: 6587407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased sensitivity to noradrenaline in glucocorticoid-treated rats: the effects of indomethacin and desipramine.
    Russo D; Fraser R; Kenyon CJ
    J Hypertens; 1990 Sep; 8(9):827-33. PubMed ID: 2172372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
    Virdis A; Neves MF; Amiri F; Viel E; Touyz RM; Schiffrin EL
    Hypertension; 2002 Oct; 40(4):504-10. PubMed ID: 12364354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin inhibits responses to all vasoconstrictors in the rat mesenteric vascular bed: restoration of responses by prostaglandin E2.
    Manku MS; Horrobin DF
    Prostaglandins; 1976 Sep; 12(3):369-76. PubMed ID: 968051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
    Rump LC; Schollmeyer P
    Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone therapy selectively increases the sensitivity to noradrenaline of the rat mesenteric circulation.
    Russo D; Fraser R; Kenyon CJ
    J Hypertens Suppl; 1989 Dec; 7(6):S126-7. PubMed ID: 2632693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone alters the participation of endothelial factors in noradrenaline vasoconstriction differently in resistance arteries from normotensive and hypertensive rats.
    Xavier FE; Blanco-Rivero J; Avendaño MS; Sastre E; Yela R; Velázquez K; Salaíces M; Balfagón G
    Eur J Pharmacol; 2011 Mar; 654(3):280-8. PubMed ID: 21262224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between aldosterone and renomedullary prostaglandins. Competitive action between aspirin and spironolactone.
    Papanicolaou N; Lefkos N; Massourides E; Marketos S; Papavassiliou J; Bariety J; Milliez P
    Experientia; 1977 Dec; 33(12):1632-4. PubMed ID: 590459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ouabain, low K+, and aldosterone on hypoxic pressor reactivity of rat lungs.
    Herget J; McMurtry IF
    Am J Physiol; 1985 Jan; 248(1 Pt 2):H55-60. PubMed ID: 3970175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of indomethacin on the microvessel reactivity of two-kidney, one-clip hypertensive rats.
    Fortes ZB; Costa SG; Nigro D; Scivoletto R; de Oliveira MA; de Carvalho MH
    Arch Int Pharmacodyn Ther; 1992; 316():75-89. PubMed ID: 1530375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
    Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
    Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central interactions between aldosterone and vasopressin on cardiovascular system.
    Janiak P; Brody MJ
    Am J Physiol; 1988 Jul; 255(1 Pt 2):R166-73. PubMed ID: 2839996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of prostaglandins in the regulation of blood pressure with special reference to vascular reactivity.
    Yoshimura M; Shikuma R; Takashina R; Yamazaki H; Takeda K; Takahashi H; Sasaki S; Okajima H; Ijichi H
    Jpn Circ J; 1984 Feb; 48(2):180-7. PubMed ID: 6142127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of pressor effects of noradrenaline and potassium ions in the rat mesenteric arteries by physiological concentrations of angiotensin II: effects of prostaglandin E2 and cortisol.
    Kondo K; Manku MS; Horrobin DF; Boucher R; Genest J
    Clin Sci Mol Med; 1977 Sep; 53(3):233-9. PubMed ID: 913046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aldosterone and spironolactone on the isolated perfused rat heart.
    Moreau D; Chardigny JM; Rochette L
    Pharmacology; 1996 Jul; 53(1):28-36. PubMed ID: 8875599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.